BusinessIGC Appoints Medical Advisor Craig Cheifetz, M.D. to Consult on the Development of Cannabis-Based, Combination TherapiesBy Nasdaq OMXMay 16, 2017, 1:58 PM UTC
BusinessIGC Appoints Medical Advisor Craig Cheifetz, M.D. to Consult on the Development of Cannabis-Based, Combination TherapiesBy Nasdaq OMXMay 16, 2017, 1:58 PM UTC
BusinessNYSE MKT Extends India Globalization Capital Compliance Plan PeriodBy Nasdaq OMXApr 21, 2017, 9:30 PM UTC
BusinessIGC Launches Phytocannabinoid Development Committee to Secure Preclinical Initiatives for IGC-501, IGC-502 and IGC-504By Nasdaq OMXFeb 13, 2017, 11:01 AM UTC
BusinessIGC Launches Phytocannabinoid Development Committee to Secure Preclinical Initiatives for IGC-501, IGC-502 and IGC-504By Nasdaq OMXFeb 13, 2017, 11:01 AM UTC
BusinessIGC Files International Applications for Cannabinoid Composition and Method PatentsBy Nasdaq OMXMar 15, 2016, 12:30 PM UTC
